Advances in the Management of Patients With Carcinoid Syndrome

Clinical Advances in Hematology & Oncology April 2017, Volume 15, Issue 4 Matthew H. Kulke, MD Director, Program in Neuroendocrine and Carcinoid Tumors Senior Physician Dana-Farber […]

When to Initiate Treatment in Myelofibrosis

Clinical Advances in Hematology & Oncology Volume 14, Issue 11, November 2016 Claire Harrison, MD Consultant Hematologist and Deputy Director Guy’s and St Thomas’ Hospital London, […]

Emerging Treatment Options for Carcinoid Syndrome

Clinical Advances in Hematology & Oncology Volume 14, Issue 9, September 2016 Matthew H. Kulke, MD Director, Program in Neuroendocrine and Carcinoid Tumors Senior Physician Dana-Farber […]

Recent Advances in the Management of Myelofibrosis

Clinical Advances in Hematology & Oncology Volume 14, Issue 8, August 2016 Ruben A. Mesa, MD Consultant Hematologist Chair, Division of Hematology & Medical Oncology Deputy […]

When to Initiate Treatment With Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical Advances in Hematology & Oncology January 2016, Volume 14, Issue 1   Neal D. Shore, MD, FACS Medical Director, CPI Carolina Urologic Research Center Atlantic […]

Use of Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Chris Parker, MD Consultant in Clinical Oncology Royal Marsden Hospital Sutton, United Kingdom There […]

Regorafenib in Metastatic Colorectal Cancer: Optimal Dosing and Patient Selection Recommendations

Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8   Axel Grothey, MD Professor of Oncology Mayo Clinic Rochester, Minnesota   In the […]

Kidney Cancer Update

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   Starting with this issue, Clinical Advances in Hematology & Oncology is launching a […]

Selecting Early Therapy in Prostate Cancer

Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2   Daniel Petrylak, MD, Director, Genitourinary Oncology Research Program, Codirector, Signal Transduction Program, Yale Comprehensive Cancer Center, Yale […]

Novel Treatments in Acute Lymphocytic Leukemia

Clinical Advances in Hematology & Oncology April 2014, Volume 12, Issue 4 Anthony S. Stein, MD  Clinical Professor, City of Hope, Duarte, California H&O  What is acute lymphocytic leukemia […]

Targeted Treatment in Sarcoma Patients

David M. Loeb, MD, PhD Associate Professor of Oncology and Pediatrics Director of the Musculoskeletal Tumor Program Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University Baltimore, […]

Epithelial-Mesenchymal Transition in Cancer Progression

Andrew J. Armstrong, MD Department of Medicine The Duke Prostate Center Duke Cancer Institute Duke University Medical Center Durham, North Carolina H&O What is epithelial-mesenchymal transition […]

Maintenance Therapy in the Treatment of Sarcoma

Isabelle Ray-Coquard, MD, PhD Medical Oncologist Centre Léon Bérard Lyon, France H&O What is the current treatment landscape in sarcoma? IRC When discussing sarcoma, it is important to […]

Treatment Approaches to Sarcoma in the Community Setting

Sant P. Chawla, MD, FRACP Director of Santa Monica Oncology Center Santa Monica, California H&O What is the treatment approach to sarcoma in the community setting? SC Sarcoma […]

New Therapies in Soft Tissue and Bone Sarcomas

Margaret von Mehren, MD Director, Sarcoma Program Fox Chase Cancer Center Philadelphia, Pennsylvania H&O What is the current treatment landscape in soft tissue and bone sarcomas? MvM Soft […]

Novel Treatments in Acute Myeloid Leukemia

Farhad Ravandi, MD Associate Professor Department of Leukemia Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, Texas H&O How common is acute […]

mTOR Inhibitors in Sarcoma

George D. Demetri, MD Director, Ludwig Center at Dana-Farber/Harvard Cancer Center and Sarcoma Center Quick Family Senior Investigator in Medical Oncology Senior Vice President for Experimental […]

Updates in the Treatment of Neuroblastoma

Shakeel Modak, MD Pediatric Oncologist Department of Pediatrics Memorial Sloan-Kettering Cancer Center New York, New York H&O Can you provide some background on neuroblastoma? SM Neuroblastoma, a tumor […]

Disease State Awareness in Sarcoma

George D. Demetri, MD Director, Center for Sarcoma and Bone Oncology Senior Vice President for Experimental Therapeutics Dana-Farber Cancer Institute Boston, Massachusetts H&O What is a sarcoma? […]

Current Management of GISTs

Charles Blanke, MD Head, Division of Medical Oncology University of British Columbia Vancouver, British Columbia, Canada H&O What are the treatment goals for patients with gastrointestinal stromal […]